Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | $20.17 | Strong Buy | $26.00 | +28.90% | 15 hours ago | |
Analyst RankingTop 9% #466 out of 5342 analysts Average Return+9.33% Win Rate55%112 out of 203 Risk vs RewardPoor Good Analyst ColorCitigroup's Geoff Meacham raised their price target on Amylyx Pharmaceuticals (NASDAQ: AMLX) by 30% from $20 to $26 on 2026/08/03. The analyst maintained their Strong Buy rating on the stock. Amylyx Pharmaceuticals will report its Q2 2026 earnings on 2026/08/06. Raising their price target in a preview note, Meacham made two points:
| ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | a day ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.